TISLELIZUMAB
Clinical trials for TISLELIZUMAB explained in plain language.
Never miss a new study
Get alerted when new TISLELIZUMAB trials appear
Sign up with your email to follow new studies for TISLELIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy hopes to outsmart tough esophageal cancer
Disease control Not yet recruitingThis study tests a new combination of drugs for people with advanced esophageal squamous cell carcinoma (a type of throat cancer). The three drugs include a targeted therapy (becotatug vedotin), an immunotherapy (tislelizumab), and standard chemotherapy. The goal is to see if thi…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Triple therapy aims to turn inoperable lung cancer into a surgical target
Disease control Not yet recruitingThis study tests whether combining an immunotherapy drug (tislelizumab) with standard chemotherapy and a targeted artery treatment can shrink stage III lung cancer that cannot be removed by surgery. About 39 adults with newly diagnosed, unresectable non-small cell lung cancer wil…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC